Bharat Immunologicals (India) Financial Ratios

Use fundamental data analysis to double-check all available reported financial drivers of Bharat Immunologicals to find out if markets are presently mispricing the company. We found twenty-two available fundamental indicators for Bharat Immunologicals Biologicals Corp Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Gross Profit, Debt to Equity and the relationship between Price to Book and Cash and Equivalents . Use Bharat Immunologicals to protect against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier. Check odds of Bharat Immunologicals to be traded at 26.07 in 30 days

Bharat Immunologicals Company Summary

Bharat Immunologicals competes with Tata Consultancy, Tata Consultancy, Reliance Industries, ITC Limited, and I T. Bharat Immunologicals Biologicals Corp Ltd offers oral polio vaccines diarrhea management kits for the management of diarrhea in young children zinc dispersible tablets and iron folic acid tablets for the treatment of iron deficiency and iron deficiency anemia. Bharat Immunologicals and Biologicals Corporationration Limited was founded in 1989 and is based in Bulandshahr India.

Bharat Immunologicals Price to Sales vs Shares Outstanding

Bharat Immunologicals Biologicals Corp Ltd is rated below average in price to sales category among related companies. It is rated below average in shares outstanding category among related companies creating about  65,424,242  of Shares Outstanding per Price to Sales.

Bharat Immunologicals Fundamentals

    
 Better Than Average     
    
 Worse Than Average Compare Bharat Immunologicals to competition
FundamentalsBharat ImmunologicalsPeer Average
Return On Asset(1.69) % (15.64) %
Profit Margin(4.18) % (5.50) %
Operating Margin(5.13) % (10.91) %
Current Valuation862.5 M152.14 B
Shares Outstanding43.18 M1.43 B
Price to Earning(21.65) times40.69 times
Price to Book2.50 times14.44 times
Price to Sales0.66 times17.81 times
Revenue1.28 B9.85 B
Gross Profit119 M21.75 B
EBITDA(56.51 M)1.41 B
Net Income(53.46 M)517.71 M
Cash and Equivalents152.27 M3.89 B
Cash per Share3.55 times5.17 times
Total Debt177.56 M7.36 B
Debt to Equity0.50 times0.72 times
Current Ratio1.69 times3.30 times
Earnings Per Share(1.24) times2.30 times
Number of Employees510.67 K
Market Capitalization1.16 B29.78 B
Z Score3.6708.73
< 18% 

Chance of Financial Distress

Bharat Immunologicals Biologicals Corp Ltd has less than 18 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
Details

Compare

Compare Bharat Immunologicals To Peers
U Singh  CFO
CFO

Opportunity Range

June 29, 2017 Opportunity Range